LPL Financial’s Virtus Biotech ETF BBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $798K | Buy |
9,608
+1,024
| +12% | +$84.2K | ﹤0.01% | 4370 |
|
|
2025
Q4 | $686K | Buy |
8,584
+2,346
| +38% | +$178K | ﹤0.01% | 4426 |
|
|
2025
Q3 | $436K | Buy |
6,238
+2,015
| +48% | +$132K | ﹤0.01% | 4735 |
|
|
2025
Q2 | $246K | Sell |
4,223
-490
| -10% | -$27.7K | ﹤0.01% | 4927 |
|
|
2025
Q1 | $276K | Sell |
4,713
-1,929
| -29% | -$118K | ﹤0.01% | 4640 |
|
|
2024
Q4 | $399K | Buy |
6,642
+1,484
| +29% | +$93.8K | ﹤0.01% | 4294 |
|
|
2024
Q3 | $324K | Buy |
5,158
+330
| +7% | +$20.6K | ﹤0.01% | 4364 |
|
|
2024
Q2 | $284K | Sell |
4,828
-300
| -6% | -$16.7K | ﹤0.01% | 4318 |
|
|
2024
Q1 | $290K | Buy |
5,128
+257
| +5% | +$15K | ﹤0.01% | 4226 |
|
|
2023
Q4 | $283K | Sell |
4,871
-354
| -7% | -$17.9K | ﹤0.01% | 4137 |
|
|
2023
Q3 | $261K | Buy |
5,225
+390
| +8% | +$20.5K | ﹤0.01% | 4039 |
|
|
2023
Q2 | $254K | Sell |
4,835
-608
| -11% | -$31.9K | ﹤0.01% | 3982 |
|
|
2023
Q1 | $268K | Buy |
5,443
+722
| +15% | +$36.2K | ﹤0.01% | 3826 |
|
|
2022
Q4 | $233K | Buy |
4,721
+15
| +0.3% | +$718 | ﹤0.01% | 3867 |
|
|
2022
Q3 | $213K | Buy |
+4,706
| New | +$217K | ﹤0.01% | 3877 |
|
|
2022
Q1 | – | Sell |
-5,795
| Closed | -$283K | – | 4197 |
|
|
2021
Q4 | $283K | Sell |
5,795
-818
| -12% | -$40.7K | ﹤0.01% | 3716 |
|
|
2021
Q3 | $337K | Sell |
6,613
-117
| -2% | -$6.03K | ﹤0.01% | 3559 |
|
|
2021
Q2 | $359K | Sell |
6,730
-446
| -6% | -$23.5K | ﹤0.01% | 3446 |
|
|
2021
Q1 | $376K | Sell |
7,176
-139
| -2% | -$7.75K | ﹤0.01% | 3283 |
|
|
2020
Q4 | $389K | Sell |
7,315
-326
| -4% | -$16.7K | ﹤0.01% | 2975 |
|
|
2020
Q3 | $364K | Sell |
7,641
-339
| -4% | -$15.8K | ﹤0.01% | 2752 |
|
|
2020
Q2 | $378K | Sell |
7,980
-81
| -1% | -$3.62K | ﹤0.01% | 2651 |
|
|
2020
Q1 | $302K | Sell |
8,061
-1,945
| -19% | -$80.4K | ﹤0.01% | 2501 |
|
|
2019
Q4 | $436K | Sell |
10,006
-26
| -0.3% | -$1.04K | ﹤0.01% | 2488 |
|
|
2019
Q3 | $360K | Sell |
10,032
-350
| -3% | -$13.4K | ﹤0.01% | 2532 |
|
|
2019
Q2 | $426K | Sell |
10,382
-3,603
| -26% | -$148K | ﹤0.01% | 2393 |
|
|
2019
Q1 | $627K | Buy |
13,985
+1,095
| +8% | +$45.9K | ﹤0.01% | 2021 |
|
|
2018
Q4 | $450K | Sell |
12,890
-145
| -1% | -$5.52K | ﹤0.01% | 2120 |
|
|
2018
Q3 | $592K | Buy |
13,035
+187
| +1% | +$8.36K | ﹤0.01% | 2101 |
|
|
2018
Q2 | $564K | Sell |
12,848
-1,711
| -12% | -$72.6K | ﹤0.01% | 2095 |
|
|
2018
Q1 | $601K | Sell |
14,559
-2,878
| -17% | -$121K | ﹤0.01% | 1988 |
|
|
2017
Q4 | $707K | Buy |
17,437
+1,629
| +10% | +$65K | ﹤0.01% | 1770 |
|
|
2017
Q3 | $657K | Sell |
15,808
-6,761
| -30% | -$270K | ﹤0.01% | 1735 |
|
|
2017
Q2 | $895K | Sell |
22,569
-5,682
| -20% | -$212K | ﹤0.01% | 1446 |
|
|
2017
Q1 | $1.05M | Buy |
28,251
+6,047
| +27% | +$221K | 0.01% | 1231 |
|
|
2016
Q4 | $725K | Buy |
22,204
+5,055
| +29% | +$165K | 0.01% | 1431 |
|
|
2016
Q3 | $567K | Sell |
17,149
-2,409
| -12% | -$74.4K | 0.01% | 1595 |
|
|
2016
Q2 | $550K | Sell |
19,558
-15,022
| -43% | -$397K | ﹤0.01% | 1590 |
|
|
2016
Q1 | $875K | Sell |
34,580
-9,182
| -21% | -$223K | ﹤0.01% | 1774 |
|
|
2015
Q4 | $1.29M | Buy |
43,762
+26,584
| +155% | +$806K | ﹤0.01% | 1470 |
|
|
2015
Q3 | $502K | Sell |
17,178
-1,341
| -7% | -$45.3K | ﹤0.01% | 1789 |
|
|
2015
Q2 | $642K | Buy |
18,519
+4,975
| +37% | +$163K | ﹤0.01% | 1703 |
|
|
2015
Q1 | $423K | Buy |
+13,544
| New | +$397K | ﹤0.01% | 1982 |
|
Other funds holding BBP
CAMG
PCIA
MSL
WI
LPL Financial's BBP Position: Q1 2026 in Review
LPL Financial increased its Virtus Biotech ETF (BBP) stake by 12% in Q1 2026, buying an estimated $84.2K and bringing the position to 9,608 shares worth $798K. The position accounts for ﹤0.01% of the portfolio, ranked #4370.
LPL Financial first reported a position in BBP in Q1 2015 and has held it in 43 quarters since. The position peaked at $1.29M in Q4 2015. 26 funds tracked by Wall St. Rank hold BBP as of Q1 2026.
- LPL Financial held 9,608 shares of Virtus Biotech ETF worth $798K as of Q1 2026.
- LPL Financial bought 1,024 Virtus Biotech ETF shares in Q1 2026, an estimated $84.2K.
- Virtus Biotech ETF made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #4370 holding.
- LPL Financial first reported a position in Virtus Biotech ETF in Q1 2015 and has held it in 43 quarters since.
- LPL Financial's Virtus Biotech ETF position peaked at $1.29M in Q4 2015.
- 26 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q1 2026.
Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.